Orgenesis Inc - ORGS Company Long-Term Liabilities

Official company branding of Orgenesis Corp (ORGS)

Orgenesis Inc. is developing B2B integration of its OMPC IT system for gene therapy management, aiming to secure a leadership position in digital healthcare. Business growth relies on collaboration with biobanks and the accessibility of treatment. This chart of the asset's market valuation reflects a figure of 0.00. The company's future success will be determined by the transition to automated software production directly within medical centers.

ORGS Orgenesis Inc: Company Long-Term Debts in the range 07/04/2022 - 10/26/2024

Analytical breakdowns for Orgenesis Inc.

- price and consensus price forecast:
Price Performance Chart orgenesis.com|ORGS - Price Target Chart
- market capitalization data:
Market Valuation Orgenesis|ORGS - Enterprise Value
- book capitalization data:
Net Asset Value per Share Orgenesis|ORGS - Book Capitalization|Capitalization to Book Value Ratio orgenesis.com|ORGS - Aggregate Company Assets
- debt and liquidity data:
Debt to Capital Orgenesis Inc.|ORGS - Long-Term Debt to Equity|Ratio of Short-Term Indebtedness to Capital Orgenesis Corporation|ORGS - Company Aggregate Debts|Debt to Net Assets Orgenesis|ORGS - Company Long-Term Debts|Short-Term Debt Orgenesis
Summary company analysis:ORGS (orgenesis.com)
Manufactured products of Orgenesis Corporation

This indicator is formed by aggregating all of the issuer's liabilities with a maturity of more than twelve months from the liabilities section of the balance sheet. The metric measures the long-term debt load, determining financial stability and the cost of servicing capital. For Orgenesis Inc. (ORGS), such loans are critical, as the company relies on external cloud services and third-party laboratories. An analysis of the company's long-term loans and borrowings allows for an assessment of vendor dependency risks. The price action regarding the company's long-term loans and borrowings reflects the pace of infrastructure scaling.

Direct competitors

veeva.com - Company Long-Term Loans and Borrowings|DOCS: Company Long-Term Debt|HQY - Company Long-Term Liabilities|Company Long-Term Debts WAY|CorVel Corp. (CRVL) - Long-Term Debt|Company Long-Term Debts Privia Health Group (PRVA)|Company Long-Term Indebtedness HURN|Certara - Company Long-Term Debt|Long-Term Debt OMCL (Omnicell Inc)|Company Long-Term Debt GoodRx Corp|Company Long-Term Loans and Borrowings Schrodinger Corp SDGR|Company Long-Term Debts PHR|OMDA - Long-Term Indebtedness|Company Long-Term Debts EVH|HSTM (HealthStream Inc) - Long-Term Debt|Company Long-Term Debt Definitive Healthcare Inc. (DH)|Company Long-Term Indebtedness Consensus Corp|Agilon Health - Company Long-Term Debts|Long-Term Debt ABSI (absci.com)|Company Long-Term Debt SY|Long-Term Debt Volume NRC Health Inc. NRC|Company Long-Term Debts SPOK (Spok Corp)|OPRX: Long-Term Debt Volume|TruBridge, Inc. - Company Long-Term Debt|Long-Term Debt Volume simulations-plus.com|SOPH - Company Long-Term Liabilities|Company Long-Term Loans and Borrowings Health Catalyst Inc.|CCLD (CareCloud, Inc.) - Company Long-Term Debts|Long-Term Debt Volume RSSS (researchsolutions.com)|DLHC - Company Long-Term Debt|Company Long-Term Indebtedness OneMedNet Corp ONMD|SCNX: Company Long-Term Debts|Healthcare Triangle Inc (HCTI) - Company Long-Term Liabilities|ispecimen.com - Company Long-Term Liabilities|BFRG (Bullfrog AI) - Long-Term Debt Volume|Company Long-Term Debt WORX (SCWorx Corp.)|Long-Term Debt MSPR|iCoreConnect Inc. (ICCT) - Company Long-Term Debt|Company Long-Term Loans and Borrowings TRxADE HEALTH Inc (MEDS)|RCM (R1 RCM) - Company Long-Term Debts|Sharecare Inc - Long-Term Indebtedness|Company Long-Term Debt STRM (Streamline Health Solutions)|SYRA - Long-Term Debt Volume|apollomed.net - Company Long-Term Debts|Long-Term Debt Volume Model N Inc|NextGen (NXGN) - Company Long-Term Liabilities